Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 302

Similar articles for PubMed (Select 9160306)

1.

p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.

Goto K, Konomoto T, Hayashi K, Kinukawa N, Naito S, Kumazawa J, Tsuneyoshi M.

Mod Pathol. 1997 May;10(5):428-37.

PMID:
9160306
2.

[p53 mutation in phenacetin-induced urothelial carcinomas].

Petersen I, Ohgaki H, Ludeke BI, Kleihues P.

Verh Dtsch Ges Pathol. 1993;77:252-5. German.

PMID:
7511292
3.

Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.

Watanabe J, Nishiyama H, Okubo K, Takahashi T, Toda Y, Habuchi T, Kakehi Y, Tada M, Ogawa O.

Urology. 2004 May;63(5):989-93.

PMID:
15135005
4.

p53 mutations in phenacetin-associated human urothelial carcinomas.

Petersen I, Ohgaki H, Ludeke BI, Kleihues P.

Carcinogenesis. 1993 Oct;14(10):2119-22.

PMID:
8222064
5.

Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.

Yamamoto S, Romanenko A, Wei M, Masuda C, Zaparin W, Vinnichenko W, Vozianov A, Lee CC, Morimura K, Wanibuchi H, Tada M, Fukushima S.

Cancer Res. 1999 Aug 1;59(15):3606-9.

6.

Metachronous multifocal development of urothelial cancers by intraluminal seeding.

Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O.

Lancet. 1993 Oct 30;342(8879):1087-8.

PMID:
8105314
8.

High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.

Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH 3rd, Busch C, Shamaa M, El-Baz M, Nichols PW, Gonzalgo ML, Elbaz M [corrected to El-Baz M], et al.

J Natl Cancer Inst. 1995 Sep 20;87(18):1383-93. Erratum in: J Natl Cancer Inst 1995 Dec 6;87(23):1807.

PMID:
7658499
9.

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ.

Am J Pathol. 1993 Nov;143(5):1389-97.

10.

Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.

Habuchi T, Takahashi R, Yamada H, Ogawa O, Kakehi Y, Ogura K, Hamazaki S, Toguchida J, Ishizaki K, Fujita J, et al.

Cancer Res. 1993 Aug 15;53(16):3795-9.

11.

Mutations of the p53 gene in carcinomas of the urinary system.

Suzuki Y, Tamura G.

Acta Pathol Jpn. 1993 Dec;43(12):745-50.

PMID:
8109252
12.

p53 gene mutations in human urothelial carcinomas: analysis by immunohistochemistry and single-strand conformation polymorphism.

Oyasu R, Nan L, Szumel RC, Kawamata H, Hirohashi S.

Mod Pathol. 1995 Feb;8(2):170-6.

PMID:
7777479
13.

Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes.

Bringuier PP, McCredie M, Sauter G, Bilous M, Stewart J, Mihatsch MJ, Kleihues P, Ohgaki H.

Int J Cancer. 1998 Oct 23;79(5):531-6.

PMID:
9761125
14.

p53 status in multiple human urothelial cancers: assessment for clonality by the yeast p53 functional assay in combination with p53 immunohistochemistry.

Yamamoto S, Tada M, Lee CC, Masuda C, Wanibuchi H, Yoshimura R, Wada S, Yamamoto K, Kishimoto T, Fukushima S.

Jpn J Cancer Res. 2000 Feb;91(2):181-9.

PMID:
10761705
15.

Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression.

Erill N, Colomer A, Verdú M, Román R, Condom E, Hannaoui N, Banús JM, Cordon-Cardo C, Puig X.

Diagn Mol Pathol. 2004 Dec;13(4):217-23.

PMID:
15538112
16.

Aberrant expression of beta-catenin and mutation of exon 3 of the beta-catenin gene in renal and urothelial carcinomas.

Zhu X, Kanai Y, Saito A, Kondo Y, Hirohashi S.

Pathol Int. 2000 Dec;50(12):945-52.

PMID:
11123760
17.

Determination of p53 protein and high-risk human papillomavirus DNA in carcinomas of the renal pelvis and ureter.

Kuwahara M, Fujisaki N, Kagawa S, Furihata M, Ohtsuki Y.

Int J Mol Med. 1998 Apr;1(4):703-7.

PMID:
9852285
18.
19.

p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON / Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma.

Gen H, Yamamoto S, Morimura K, Min W, Mitsuhashi M, Murai T, Mori S, Hosono M, Oohara T, Makino S, Wanibuchi H, Fukushima S.

Jpn J Cancer Res. 2001 Dec;92(12):1278-83.

PMID:
11749692
20.

No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.

Stoehr R, Brinkmann A, Filbeck T, Gamper C, Wild P, Blaszyk H, Hofstaedter F, Knuechel R, Hartmann A.

Oncol Rep. 2004 Jan;11(1):137-41.

PMID:
14654916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk